These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 39152502)

  • 1. Comparative analysis of delivered and planned doses in target volumes for lung stereotactic ablative radiotherapy.
    Yu GB; Kim JI; Kim HJ; Lee S; Choi CH; Kang S
    Radiat Oncol; 2024 Aug; 19(1):110. PubMed ID: 39152502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technical Note: Dosimetric evaluation of Monte Carlo algorithm in iPlan for stereotactic ablative body radiotherapy (SABR) for lung cancer patients using RTOG 0813 parameters.
    Pokhrel D; Badkul R; Jiang H; Kumar P; Wang F
    J Appl Clin Med Phys; 2015 Jan; 16(1):5058. PubMed ID: 25679161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of the delivered dose based on cone-beam CT and deformable image registration for non-small cell lung cancer treated with hypofractionated radiotherapy.
    Wang B; Wang DQ; Lin MS; Lu SP; Zhang J; Chen L; Li QW; Cheng ZK; Liu FJ; Guo JY; Liu H; Qiu B
    BMC Cancer; 2020 Nov; 20(1):1112. PubMed ID: 33198676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic ablative radiation therapy for subcentimeter lung tumors: clinical, dosimetric, and image guidance considerations.
    Louie AV; Senan S; Dahele M; Slotman BJ; Verbakel WF
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):843-9. PubMed ID: 25585783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer.
    Tamihardja J; Cirsi S; Kessler P; Razinskas G; Exner F; Richter A; Polat B; Flentje M
    Radiat Oncol; 2021 Oct; 16(1):205. PubMed ID: 34702305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric Study of Deep Learning-Guided ITV Prediction in Cone-beam CT for Lung Stereotactic Body Radiotherapy.
    Zhang S; Lv B; Zheng X; Li Y; Ge W; Zhang L; Mo F; Qiu J
    Front Public Health; 2022; 10():860135. PubMed ID: 35392465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy.
    Shaverdian N; Tenn S; Veruttipong D; Wang J; Hegde J; Lee C; Cao M; Agazaryan N; Steinberg M; Kupelian P; Lee P
    Br J Radiol; 2016; 89(1059):20150963. PubMed ID: 26764282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLC tracking for lung SABR is feasible, efficient and delivers high-precision target dose and lower normal tissue dose.
    Booth J; Caillet V; Briggs A; Hardcastle N; Angelis G; Jayamanne D; Shepherd M; Podreka A; Szymura K; Nguyen DT; Poulsen P; O'Brien R; Harris B; Haddad C; Eade T; Keall P
    Radiother Oncol; 2021 Feb; 155():131-137. PubMed ID: 33152399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond conventional bounds: Surpassing system limits for stereotactic ablative (SAbR) lung radiotherapy using CBCT-based adaptive planning system.
    Gonzalez Y; Visak J; Overman L; Liao CY; Yen A; Zhuang T; Cai B; Godley A; Zhang Y; Timmerman R; Iyengar P; Westover K; Parsons D; Lin MH
    J Appl Clin Med Phys; 2024 Aug; 25(8):e14375. PubMed ID: 38712917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose escalated liver stereotactic body radiation therapy at the mean respiratory position.
    Velec M; Moseley JL; Dawson LA; Brock KK
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1121-1128. PubMed ID: 25035217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
    Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
    Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ITV versus mid-ventilation for treatment planning in lung SBRT: a comparison of target coverage and PTV adequacy by using in-treatment 4D cone beam CT.
    Bellec J; Arab-Ceschia F; Castelli J; Lafond C; Chajon E
    Radiat Oncol; 2020 Mar; 15(1):54. PubMed ID: 32127010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of conformal arc plans by using deformable margin delineation method for stereotactic lung radiotherapy.
    Güngör G; Demir M; Aydın G; Yapıcı B; Atalar B; Özyar E
    J Appl Clin Med Phys; 2018 Jan; 19(1):184-193. PubMed ID: 29218841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.
    Takahashi W; Yamashita H; Kida S; Masutani Y; Sakumi A; Ohtomo K; Nakagawa K; Haga A
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):426-31. PubMed ID: 23562767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative planning study for lung SABR between tri-Co-60 magnetic resonance image guided radiation therapy system and volumetric modulated arc therapy.
    Park JM; Park SY; Kim HJ; Wu HG; Carlson J; Kim JI
    Radiother Oncol; 2016 Aug; 120(2):279-85. PubMed ID: 27401404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric comparison of four-dimensional computed tomography based internal target volume against variations in respiratory motion during treatment between volumetric modulated arc therapy and three-dimensional conformal radiotherapy in lung stereotactic body radiotherapy.
    Fujimoto D; Takatsu J; Hara N; Oshima M; Tomihara J; Segawa E; Inoue T; Shikama N
    Radiol Phys Technol; 2024 Mar; 17(1):143-152. PubMed ID: 37930563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
    Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
    Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Planning Target Volume D95 and Mean Dose Should Be Considered for Optimal Local Control for Stereotactic Ablative Radiation Therapy.
    Zhao L; Zhou S; Balter P; Shen C; Gomez DR; Welsh JD; Lin SH; Chang JY
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1226-35. PubMed ID: 27209498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of interfractional variation of the centroid position and volume of internal target volume during stereotactic body radiotherapy of lung cancer using cone-beam computed tomography.
    Sun Y; Ge H; Cheng S; Yang C; Zhu Q; Li D; Tian Y
    J Appl Clin Med Phys; 2016 Mar; 17(2):461-472. PubMed ID: 27074466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.